QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
QQQ   419.93 (-0.82%)
AAPL   165.58 (-0.87%)
MSFT   402.29 (-0.49%)
META   490.73 (-2.21%)
GOOGL   155.13 (-0.56%)
AMZN   176.75 (-1.38%)
TSLA   150.09 (+0.11%)
NVDA   824.46 (-2.63%)
AMD   151.82 (-2.10%)
NIO   3.86 (-3.50%)
BABA   68.77 (-0.16%)
T   16.33 (+0.00%)
F   12.13 (+0.58%)
MU   109.43 (-2.23%)
GE   151.44 (-0.98%)
CGC   7.69 (-1.79%)
DIS   111.90 (-0.47%)
AMC   3.14 (+7.53%)
PFE   25.62 (+0.91%)
PYPL   62.21 (+0.18%)
XOM   120.34 (+1.54%)
Free Trial

Aimmune Therapeutics (AIMT) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free AIMT Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Headlines
Stock Analysis
SourceHeadline
finance.yahoo.com logoAimmune Therapeutics to Present New Data for PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] at the EAACI Hybrid Congress 2022
finance.yahoo.com - June 30 at 9:27 PM
financialpost.com logoAimmune Therapeutics Presents New PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Data on Immunological Outcomes of Long-Term Daily Oral Immunotherapy at the EAACI PAAM Digital Meeting
financialpost.com - November 12 at 2:09 PM
finance.yahoo.com logoAimmune Closes Enrolment in Phase III Peanut Allergy Study
finance.yahoo.com - October 26 at 6:45 AM
ca.finance.yahoo.com logoAimmune’s PALISADE-ARC004 Longitudinal Study Showed PALFORZIA® Safety and Efficacy Increased Over Time in Patients with Peanut Allergy
ca.finance.yahoo.com - August 4 at 9:48 AM
Get Aimmune Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIMT and its competitors with MarketBeat's FREE daily newsletter.

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

AIMT Media Mentions By Week

AIMT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AIMT
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

AIMT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AIMT Articles
This Week
▼
0

0
▲
AIMT Articles
Average Week

Get Aimmune Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AIMT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AIMT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research